CD274 and neoplasm: In addition, other studies are necessary to determine if PDL1 expression or tumor-infiltrating T-cells mediate an impact on tumor growth after miR-34 delivery and to distinguish the effects of miR-34a on oncogenic pathways from that affecting tumor immune evasion.